Skip to main content
Year archive

ADALTA LIMITED — 2026 filings

All 34 regulatory filings released by ADALTA LIMITED (1AD) in 2026, sourced directly from the official regulator.

34 Filings
2026 Period
2026 filings (34)
Filing Released Lang
Application for quotation of securities - 1AD 6 pages 18.4KB
Share Issue/Capital Change
2026-05-17 English
Cleansing Notice 1
Share Issue/Capital Change
2026-05-17 English
Notice of EGM & Proxy Form 22 pages 369.7KB
Proxy Solicitation & Information Statement
2026-05-14 English
Webinar presentation - new hope for mesothelioma patients 16 pages 1.4MB
Investor Presentation
2026-05-10 English
Investor webinar - new hope for mesothelioma patients 2 pages 215.4KB
Regulatory Filings
2026-05-06 English
$2.5m placement 4 pages 269.5KB
Regulatory Filings
2026-05-03 English
Proposed issue of securities - 1AD 5 pages 19.3KB
Regulatory Filings
2026-05-03 English
Proposed issue of securities - 1AD 6 pages 21.2KB
Regulatory Filings
2026-05-03 English
Quarterly Appendix 4C and Activities Report 10 pages 621.3KB
Regulatory Filings
2026-04-29 English
Trading Halt 2 pages 420.8KB
Regulatory Filings
2026-04-29 English
BZDS1901 manufacturing agreement 6 pages 502.5KB
Regulatory Filings
2026-04-28 English
Automated cell therapy manufacturing MoU 4 pages 271.4KB
Regulatory Filings
2026-04-20 English
Board Change and Appendix 3Z 4 pages 453.1KB
Board/Management Information
2026-04-16 English
Notification of cessation of securities - 1AD 4 pages 14.8KB
Regulatory Filings
2026-04-01 English
BZDS1901 clinical update 4 pages 400.9KB
Capital/Financing Update
2026-03-31 English
AdCella and SHcell hold first JDC meeting 3 pages 397.8KB
Capital/Financing Update
2026-03-26 English
New AD-214 patent granted 2 pages 238.7KB
Regulatory Filings
2026-03-19 English
Initial Director's Interest Notice (FD) 2 pages 250.4KB
Director's Dealing
2026-03-17 English
Fadi Diab to join AdAlta Board 2 pages 231.6KB
Board/Management Information
2026-03-17 English
AdCella expands clinical advisory board 3 pages 730.9KB
Board/Management Information
2026-03-03 English
AdCella Clinical Advisory Board convened 3 pages 799.7KB
Regulatory Filings
2026-02-25 English
Half Yearly Report and Accounts 24 pages 1.3MB
Interim / Quarterly Report
2026-02-19 English
ANZ Biologics Festival presentation 21 pages 1.9MB
Investor Presentation
2026-02-03 English
Quarterly Appendix 4C and Activities Report 10 pages 402.2KB
Interim / Quarterly Report
2026-01-29 English
Application for quotation of securities - 1AD 7 pages 20.8KB
Share Issue/Capital Change
2026-01-29 English
Application for quotation of securities - 1AD 7 pages 20.9KB
Capital/Financing Update
2026-01-29 English
Cleansing Notice 1 page 195.6KB
Capital/Financing Update
2026-01-29 English
AdCella milestones and regulatory progress 3 pages 251.4KB
Capital/Financing Update
2026-01-20 English
East to West webinar presentation - BZDS1901 17 pages 1.3MB
Investor Presentation
2026-01-14 English
Placement raises A$1.2 million 3 pages 247.8KB
Capital/Financing Update
2026-01-12 English
Proposed issue of securities - 1AD 5 pages 19.1KB
Capital/Financing Update
2026-01-12 English
Proposed issue of securities - 1AD 6 pages 20.9KB
Capital/Financing Update
2026-01-12 English
Upcoming investor webinar 2 pages 276.3KB
Investor Presentation
2026-01-12 English
CAR-T collaboration agreement 7 pages 726.5KB
Capital/Financing Update
2026-01-01 English